Literature DB >> 22028333

Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes.

Jessica Dement-Brown1, Christopher S Newton, Tomoko Ise, Bazarragchaa Damdinsuren, Satoshi Nagata, Mate Tolnay.   

Abstract

The biological roles of B cell membrane proteins in the FCRL family are enigmatic. FCRL proteins, including FCRL5, were shown to modulate early BCR signaling, although the subsequent, functional consequences of receptor engagement are poorly understood. We found that FCRL5 surface protein itself was induced temporarily upon BCR stimulation of human, naive B cells, indicating precise control over timing of FCRL5 engagement. Cross-linking of FCRL5 on cells induced to express FCRL5 enhanced B cell proliferation significantly. This enhancement required costimulation of the BCR and TLR9, two signals required for optimal proliferation of naive B cells, whereas T cell help in the form of anti-CD40 and IL-2 was dispensable. In addition, we found that FCRL5 stimulation generated a high proportion of cells displaying surface IgG and IgA. Optimal development of cells expressing switched isotypes required T cell help, in addition to stimuli found necessary for enhanced proliferation. Surprisingly, cells that developed upon FCRL5 stimulation simultaneously displayed surface IgM, IgG, and IgA. Cells expressing multiple Ig isotypes were described in hairy cell leukemia, a disease in which FCRL5 is overexpressed. Enhanced proliferation and downstream isotype expression upon FCRL5 stimulation could reflect a physiological role for FCRL5 in the expansion and development of antigen-primed B cells. In addition, FCRL5 may promote growth of malignant cells in hairy cell leukemia and other FCRL5-expressing tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22028333     DOI: 10.1189/jlb.0211096

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  22 in total

Review 1.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

2.  CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.

Authors:  Benjamin Terrier; Satoshi Nagata; Tomoko Ise; Michelle Rosenzwajg; Ira Pastan; David Klatzmann; David Saadoun; Patrice Cacoub
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure.

Authors:  Zhaochun Chen; Giacomo Diaz; Teresa Pollicino; Huaying Zhao; Ronald E Engle; Peter Schuck; Chen-Hsiang Shen; Fausto Zamboni; Zhifeng Long; Juraj Kabat; Davide De Battista; Kevin W Bock; Ian N Moore; Kurt Wollenberg; Cinque Soto; Sugantha Govindarajan; Peter D Kwong; David E Kleiner; Robert H Purcell; Patrizia Farci
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

4.  Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.

Authors:  Swati Phalke; Katja Aviszus; Kira Rubtsova; Anatoly Rubtsov; Briana Barkes; Linda Powers; Brenda Warner; James L Crooks; John W Kappler; Evans R Fernández-Pérez; Lisa A Maier; Nabeel Hamzeh; Philippa Marrack
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

5.  Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.

Authors:  Scott A Jenks; Kevin S Cashman; Esther Zumaquero; Urko M Marigorta; Aakash V Patel; Xiaoqian Wang; Deepak Tomar; Matthew C Woodruff; Zoe Simon; Regina Bugrovsky; Emily L Blalock; Christopher D Scharer; Christopher M Tipton; Chungwen Wei; S Sam Lim; Michelle Petri; Timothy B Niewold; Jennifer H Anolik; Greg Gibson; F Eun-Hyung Lee; Jeremy M Boss; Frances E Lund; Ignacio Sanz
Journal:  Immunity       Date:  2018-10-09       Impact factor: 31.745

6.  FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.

Authors:  Fu Jun Li; Daniel M Schreeder; Ran Li; Jiongru Wu; Randall S Davis
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

7.  Adaptation to infectious disease exposure in indigenous Southern African populations.

Authors:  Katharine A Owers; Per Sjödin; Carina M Schlebusch; Pontus Skoglund; Himla Soodyall; Mattias Jakobsson
Journal:  Proc Biol Sci       Date:  2017-04-12       Impact factor: 5.349

8.  Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors.

Authors:  Andrea Franco; Bazarragchaa Damdinsuren; Tomoko Ise; Jessica Dement-Brown; Huifang Li; Satoshi Nagata; Mate Tolnay
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

Review 9.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis.

Authors:  Hao D Cheng; Henning Stöckmann; Barbara Adamczyk; Ciara A McManus; Altan Ercan; Ingrid A Holm; Pauline M Rudd; Margaret E Ackerman; Peter A Nigrovic
Journal:  Glycobiology       Date:  2017-12-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.